Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease

Area of Science:

• Cardiology
• Endocrinology
• Pathophysiology

Background:

• Diabetic cardiomyopathy presents as diastolic dysfunction, progressing to heart failure.
• It occurs independently of traditional risk factors like hypertension and dyslipidemia.
• Insulin resistance, hyperinsulinemia, and hyperglycemia are independent risk factors.

Purpose of the Study:

• To review the relationship between insulin resistance, hyperglycemia, and cardiac dysfunction.
• To summarize pathophysiological mechanisms of diabetic cardiomyopathy.
• To explore potential preventative and therapeutic strategies.

Main Methods:

• Literature review of existing research on diabetic cardiomyopathy.
• Analysis of pathophysiological factors including metabolic disorders, RAAS activation, oxidative stress, and inflammation.
• Inclusion of recent findings on endothelial cells and exosomes.

Main Results:

• Diabetes-related factors promote interstitial fibrosis, cardiac stiffness, and diastolic dysfunction.
• Systolic dysfunction and clinical heart failure develop in later stages.
• Dysregulation of coronary endothelial cells and exosomes contributes to the pathology.

Conclusions:

• Insulin resistance, hyperinsulinemia, and hyperglycemia are central to diabetic cardiomyopathy development.
• Multiple pathophysiological pathways converge to cause cardiac fibrosis and dysfunction.
• Further research into preventative and therapeutic strategies is warranted.